What’s Next for Thermo Fisher Scientific Inc. (TMO) After Reaching Record High?

July 17, 2017 - By Marie Mckinney

Investors sentiment increased to 1.05 in Q4 2016. Its up 0.26, from 0.79 in 2016Q3. It improved, as 52 investors sold Thermo Fisher Scientific Inc. shares while 371 reduced holdings. 116 funds opened positions while 329 raised stakes. 330.70 million shares or 0.57% less from 332.58 million shares in 2016Q3 were reported.
First Quadrant Limited Partnership Ca invested in 0.32% or 111,710 shares. Usca Ria Ltd Limited Liability Company accumulated 4,384 shares or 0.1% of the stock. Lenox Wealth Advisors holds 0.02% or 334 shares. Morgan Dempsey Capital Mngmt Limited Co reported 2,280 shares stake. Missouri-based Company National Bank & Trust has invested 0.44% in Thermo Fisher Scientific Inc. (NYSE:TMO). Veritas Investment Ltd Liability Partnership holds 366,722 shares or 9.15% of its portfolio. Fred Alger Incorporated has 0.28% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Victory Mngmt owns 14,655 shares. Peloton Wealth Strategists invested 1.5% in Thermo Fisher Scientific Inc. (NYSE:TMO). Amp Capital Investors reported 0.14% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Eagleclaw Managment Ltd Llc accumulated 9,550 shares. First accumulated 4,788 shares or 0.1% of the stock. Bluemountain Cap Mgmt Ltd Limited Liability Company accumulated 0.01% or 4,327 shares. 1,020 are held by Carroll Associates. Old Retail Bank In holds 102,409 shares or 0.83% of its portfolio.

Since March 6, 2017, it had 0 insider purchases, and 9 sales for $12.45 million activity. On Friday, March 10 the insider WILVER PETER M sold $1.58 million. On Monday, March 6 HOOGASIAN SETH H sold $498,667 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 3,142 shares. CASPER MARC N had sold 20,000 shares worth $3.46 million on Thursday, June 1. Williamson Stephen sold $396,775 worth of stock or 2,500 shares. Another trade for 4,049 shares valued at $642,617 was made by Loewald Thomas W on Monday, March 6.

The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) reached all time high today, Jul, 17 and still has $191.64 target or 6.00 % above today’s $180.79 share price. This indicates more upside for the $71.09 billion company. This technical setup was reported by Barchart.com. If the $191.64 PT is reached, the company will be worth $4.27 billion more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock decreased 0.09% or $0.16 during the last trading session, reaching $180.79. About 1.30M shares traded or 1.56% up from the average. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since July 17, 2016 and is uptrending. It has underperformed by 1.13% the S&P500.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on July, 27. They expect $2.25 earnings per share, up 10.84 % or $0.22 from last year’s $2.03 per share. TMO’s profit will be $884.74M for 20.09 P/E if the $2.25 EPS becomes a reality. After $2.08 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 8.17 % EPS growth.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 15 analysts covering Thermo Fisher Scientific (NYSE:TMO), 13 have Buy rating, 0 Sell and 2 Hold. Therefore 87% are positive. Thermo Fisher Scientific had 34 analyst reports since July 24, 2015 according to SRatingsIntel. On Thursday, September 22 the stock rating was initiated by JP Morgan with “Overweight”. The rating was maintained by Jefferies on Thursday, March 30 with “Hold”. On Tuesday, December 8 the stock rating was upgraded by Goldman Sachs to “Americas Conviction Buy List”. Barclays Capital maintained it with “Overweight” rating and $175 target in Tuesday, July 19 report. As per Tuesday, October 6, the company rating was initiated by Argus Research. Deutsche Bank initiated Thermo Fisher Scientific Inc. (NYSE:TMO) on Thursday, January 7 with “Buy” rating. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Hold” rating by Jefferies on Thursday, July 13. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Friday, April 29 by Jefferies. The rating was maintained by Leerink Swann with “Buy” on Friday, April 28. As per Friday, September 9, the company rating was downgraded by Cleveland.

More important recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Nasdaq.com which released: “Buffington Mohr McNeal Buys Thermo Fisher Scientific Inc, Guggenheim …” on July 14, 2017, also Prnewswire.com published article titled: “Thermo Fisher Scientific Adds Three New Products to Leading Semiconductor …”, Zacks.com published: “Why Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock?” on July 17, 2017. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) was released by: Nasdaq.com and their article: “Thermo Fisher Gets FDA’s PMA for Oncomine Dx Target Test” with publication date: June 27, 2017.

Thermo Fisher Scientific Inc. develops, makes and sells a range of products. The company has market cap of $71.09 billion. The Firm provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It has a 32.94 P/E ratio. It operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.